mRNA Lipid Nanoparticle-Mediated Pyroptosis Sensitizes Immunologically Cold Tumors to Checkpoint Immunotherapy

Researchers reported a single-agent mRNA nanomedicine-based strategy that utilized mRNA lipid nanoparticles encoding only the N-terminus of gasdermin to trigger pyroptosis, eliciting robust antitumor immunity.